1. PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma
   Janine Stutterheim et al, 2008, Journal of Clinical Oncology CrossRef
2. Isolation of viable cancer cells in antibody-functionalized microfluidic devices
   Xiangjun Zheng et al, 2014, Biomicrofluidics CrossRef
3. Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse
   Amos H. P. Loh et al, 2022, Frontiers in Oncology CrossRef